George A. Scangos
2011 - Biogen
In 2011, George A. Scangos earned a total compensation of $11.3M as Chief Executive Officer at Biogen, a 20% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $6,016 |
|---|---|
| Non-Equity Incentive Plan | $2,700,000 |
| Salary | $1,242,308 |
| Stock Awards | $7,235,199 |
| Other | $147,918 |
| Total | $11,331,441 |
Scangos received $7.2M in stock awards, accounting for 64% of the total pay in 2011.
Scangos also received $6K of change in pension value and nonqualified deferred compensation earnings, $2.7M in non-equity incentive plan, $1.2M in salary and $147.9K in other compensation.
Rankings
In 2011, George A. Scangos' compensation ranked 286th out of 10,747 executives tracked by ExecPay. In other words, Scangos earned more than 97.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 286 out of 10,747 | 97th |
Division Manufacturing | 93 out of 3,958 | 98th |
Major group Chemicals And Allied Products | 22 out of 1,031 | 98th |
Industry group Drugs | 12 out of 779 | 99th |
Industry Biological Products, Except Diagnostic Substances | 2 out of 159 | 99th |
Source: SEC filing on April 30, 2014.
Scangos' colleagues
We found five more compensation records of executives who worked with George A. Scangos at Biogen in 2011.